Multi-step encapsulation of chemotherapy and gene silencing agents in functionalized mesoporous silica nanoparticles
出版年份 2017 全文链接
标题
Multi-step encapsulation of chemotherapy and gene silencing agents in functionalized mesoporous silica nanoparticles
作者
关键词
-
出版物
Nanoscale
Volume 9, Issue 16, Pages 5329-5341
出版商
Royal Society of Chemistry (RSC)
发表日期
2017-03-23
DOI
10.1039/c7nr00377c
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phosphorescent iridium(III)-bis-N-heterocyclic carbene complexes as mitochondria-targeted theranostic and photodynamic anticancer agents
- (2015) Yi Li et al. BIOMATERIALS
- Breast cancer statistics, 2015: Convergence of incidence rates between black and white women
- (2015) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Safety of Nanoparticles in Medicine
- (2015) Joy Wolfram et al. CURRENT DRUG TARGETS
- Anticancer drug nanomicelles formed by self-assembling amphiphilic dendrimer to combat cancer drug resistance
- (2015) Tuo Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Small-Molecule Drug Conjugate for the Treatment of Carbonic Anhydrase IX Expressing Tumors
- (2014) Nikolaus Krall et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Improving Conventional Enhanced Permeability and Retention (EPR) Effects; What Is the Appropriate Target?
- (2014) Hisataka Kobayashi et al. Theranostics
- Cyclodextrin and Polyethylenimine Functionalized Mesoporous Silica Nanoparticles for Delivery of siRNA Cancer Therapeutics
- (2014) Jianliang Shen et al. Theranostics
- Multifunctional Gold Nanorods for siRNA Gene Silencing and Photothermal Therapy
- (2014) Jianliang Shen et al. Advanced Healthcare Materials
- Codelivery of an Optimal Drug/siRNA Combination Using Mesoporous Silica Nanoparticles To Overcome Drug Resistance in Breast Cancer in Vitro and in Vivo
- (2013) Huan Meng et al. ACS Nano
- High Capacity Nanoporous Silicon Carrier for Systemic Delivery of Gene Silencing Therapeutics
- (2013) Jianliang Shen et al. ACS Nano
- Regulation and function of pyruvate kinase M2 in cancer
- (2013) Weiwei Yang et al. CANCER LETTERS
- Shrinkage of pegylated and non-pegylated liposomes in serum
- (2013) Joy Wolfram et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Polyethylenimine and chitosan carriers for the delivery of RNA interference effectors
- (2013) Roberto Molinaro et al. Expert Opinion on Drug Delivery
- Cationic Bovine Serum Albumin Based Self-Assembled Nanoparticles as siRNA Delivery Vector for Treating Lung Metastatic Cancer
- (2013) Jianfeng Han et al. Small
- Targeting cellular metabolism to improve cancer therapeutics
- (2013) Y Zhao et al. Cell Death & Disease
- Multifunctional nanocarriers
- (2012) Vladimir P. Torchilin ADVANCED DRUG DELIVERY REVIEWS
- Multifunctional Mesoporous Silica Nanoparticles for Cancer-Targeted and Controlled Drug Delivery
- (2012) Quan Zhang et al. ADVANCED FUNCTIONAL MATERIALS
- Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
- (2012) Fangqiong Tang et al. ADVANCED MATERIALS
- Targeted therapy for triple-negative breast cancer: Where are we?
- (2012) Michael J. Duffy et al. INTERNATIONAL JOURNAL OF CANCER
- Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression
- (2012) Michael S. Goldberg et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A magnetic mesoporous silica nanoparticle-based drug delivery system for photosensitive cooperative treatment of cancer with a mesopore-capping agent and mesopore-loaded drug
- (2012) Nikola Ž. Knežević et al. Nanoscale
- M2 isoform of pyruvate kinase is dispensable for tumor maintenance and growth
- (2012) M. Cortes-Cros et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Emerging roles of PKM2 in cell metabolism and cancer progression
- (2012) Weibo Luo et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers
- (2011) Amirali Popat et al. Nanoscale
- Engineered Design of Mesoporous Silica Nanoparticles to Deliver Doxorubicin and P-Glycoprotein siRNA to Overcome Drug Resistance in a Cancer Cell Line
- (2010) Huan Meng et al. ACS Nano
- Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies
- (2010) Nikolai Khlebtsov et al. CHEMICAL SOCIETY REVIEWS
- Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles – opportunities & challenges
- (2010) Jessica M. Rosenholm et al. Nanoscale
- Delivering nanomedicine to solid tumors
- (2010) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- Polyethyleneimine Coating Enhances the Cellular Uptake of Mesoporous Silica Nanoparticles and Allows Safe Delivery of siRNA and DNA Constructs
- (2009) Tian Xia et al. ACS Nano
- A proteomic approach links decreased pyruvate kinase M2 expression to oxaliplatin resistance in patients with colorectal cancer and in human cell lines
- (2009) E. Martinez-Balibrea et al. MOLECULAR CANCER THERAPEUTICS
- The promises and pitfalls of RNA-interference-based therapeutics
- (2009) Daniela Castanotto et al. NATURE
- Knocking down barriers: advances in siRNA delivery
- (2009) Kathryn A. Whitehead et al. NATURE REVIEWS DRUG DISCOVERY
- Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers☆
- (2008) I SLOWING et al. ADVANCED DRUG DELIVERY REVIEWS
- Synthesis and Characterization of Positive-Charge Functionalized Mesoporous Silica Nanoparticles for Oral Drug Delivery of an Anti-Inflammatory Drug
- (2008) Chia-Hung Lee et al. ADVANCED FUNCTIONAL MATERIALS
- Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer
- (2008) Nancy U. Lin et al. CANCER
- Multi-functional nanocarriers to overcome tumor drug resistance
- (2008) Lara S. Jabr-Milane et al. CANCER TREATMENT REVIEWS
- Cancer Cell Metabolism: Warburg and Beyond
- (2008) Peggy P. Hsu et al. CELL
- An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor
- (2008) Sumio Chono et al. JOURNAL OF CONTROLLED RELEASE
- Pyruvate kinase M2 is a phosphotyrosine-binding protein
- (2008) Heather R. Christofk et al. NATURE
- Nanoparticle therapeutics: an emerging treatment modality for cancer
- (2008) Mark E. Davis et al. NATURE REVIEWS DRUG DISCOVERY
- Nanotechnology and Cancer
- (2007) James R. Heath et al. Annual Review of Medicine
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started